Foghorn Therapeutics Q3'26 Earnings Preview: EPS Estimate at $(0.24)
Foghorn Therapeutics is scheduled to report Q3'26 results on November 10; the report time is not specified. Revenue is estimated at $7.10 million, with EPS estimated at $(0.24).
FHTX (Foghorn Therapeutics Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 7.10 million USD with EPS (earnings per share) anticipated at (0.24) USD. Learn more detail…